Life Sciences
Accelerating drug development and patient outcomes through technology
IBU partners with pharmaceutical companies, biotech firms, CROs and medical device manufacturers to modernise clinical trial management, automate regulatory submissions, strengthen pharmacovigilance, and deploy AI-driven drug discovery platforms.
Discuss Your ProjectThe Sector Challenge
Life sciences companies face intense pressure to reduce time-to-market for new therapies, meet evolving FDA, EMA and MHRA requirements, and harness the power of real-world data and AI. IBU brings deep expertise across the drug development lifecycle — from discovery and clinical trials through to commercial launch and post-market surveillance — helping organisations accelerate innovation while maintaining the highest standards of data integrity and regulatory compliance.
What We Solve
- Clinical trial management system (CTMS) modernisation
- Regulatory submission automation (eCTD, IDMP)
- Pharmacovigilance and adverse event reporting
- Real-world data and evidence generation
- AI-assisted drug discovery and target identification
- GxP compliance and data integrity
- Laboratory information management (LIMS) integration
- Supply chain serialisation and track-and-trace
- Commercial launch analytics and market access
- Medical device software (SaMD) development
Our Capabilities in Life Sciences
Business Outcomes
Faster Trial Execution
Integrated CTMS and eTMF platforms reduce trial start-up times and improve site performance monitoring.
Regulatory Confidence
Automated eCTD compilation and IDMP data standards reduce submission errors and accelerate agency review.
Data Integrity
GxP-validated systems and audit trail frameworks ensure data integrity across the full development lifecycle.
AI-Accelerated Discovery
Machine learning models for target identification and compound screening compress early-stage discovery timelines.
Patient Safety
Real-time pharmacovigilance platforms detect safety signals earlier and automate expedited reporting obligations.
Commercial Readiness
Launch analytics and market access platforms support pricing, reimbursement and commercial performance tracking.
Ready to transform your life sciences operations?
Speak with an IBU specialist who understands your sector's unique pressures and opportunities.